Mary Kay Fenton

2008 - Achillion Pharmaceuticals

In 2008, Mary Kay Fenton earned a total compensation of $285.8K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 31% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$37,800
Option Awards$31,401
Salary$210,000
Other$6,581
Total$285,782

Fenton received $210K in salary, accounting for 73% of the total pay in 2008.

Fenton also received $37.8K in non-equity incentive plan, $31.4K in option awards and $6.6K in other compensation.

Rankings

In 2008, Mary Kay Fenton's compensation ranked 8,011th out of 9,135 executives tracked by ExecPay. In other words, Fenton earned more than 12.3% of executives.

ClassificationRankingPercentile
All
8,011
out of 9,135
12th
Division
Manufacturing
3,042
out of 3,436
12th
Major group
Chemicals And Allied Products
715
out of 815
12th
Industry group
Drugs
520
out of 597
13th
Industry
Pharmaceutical Preparations
363
out of 408
11th
Source: SEC filing on April 19, 2011.

Fenton's colleagues

We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2008.

2008

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2008

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2008

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2008

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

News

You may also like